SCHEMBL11304990

SCHEMBL11304990

O=C(NO)c1ccc(N(c2cccc3ncccc23)C2CCNC2=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 13/20 0.48
▸ HDAC8 Q9BY41 6/20 0.44
▸ HDAC1 Q13547 5/20 0.44
▸ HDAC3 O15379 3/20 0.44
▸ HDAC2 Q92769 3/20 0.44
▸ HDAC5 Q9UQL6 3/20 0.44
▸ HDAC7 Q8WUI4 2/20 0.44
▸ HDAC9 Q9UKV0 2/20 0.44
▸ HDAC10 Q969S8 2/20 0.44
▸ HDAC11 Q96DB2 2/20 0.44
▸ NCOR2 Q9Y618 2/20 0.44
▸ HDAC4 P56524 1/20 0.44
▸ ACHE P22303 1/20 0.40
▸ MEN1 O00255 2/20 0.38
▸ PABPC1 P11940 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ EIF4H Q15056 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ P2RX7 Q99572 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11296122 0.86 HDAC6 (0.43) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL11301410 0.85 HDAC6 (0.47) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL11301790 0.80 HDAC6 (0.36) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL11303351 0.79 HDAC6 (0.40) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL11299163 0.79 HDAC6 (0.40) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL11301603 0.76 HDAC6 (0.38) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL11305647 0.75 HDAC6 (0.41) HDAC6HDAC8HDAC1HDAC3HDAC11
SCHEMBL11301754 0.75 PSEN1 (0.42) HDAC6HDAC8HDAC1HDAC2ALDH1A1
SCHEMBL11297375 0.74 HDAC8 (0.44) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL11298752 0.74 HDAC8 (0.42) HDAC6HDAC8HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback